Novartis files MorphoSys takeover for Austrian approval
Novartis has filed its plan to buy MorphoSys, a developer of cancer treatments, for approval in Austria. The national competition watchdog has until March 11 to decide whether to clear the...To view the full article, register now.
Already a subscriber? Click here to view full article